NeuroHTS™ Poster - ISSCR 2026
Structured human iPSC-derived neuronal networks enable multiparametric detection of disease-specific phenotypes in Alzheimer's and Parkinson's disease.
Structured human iPSC-derived neuronal networks enable multiparametric detection of disease-specific phenotypes in Alzheimer's and Parkinson's disease.
Using the Neuro-High Throughput Screening (HTS) Platform to Accelerate CIPN and Pain Modelling for Drug Discovery.
Human iPSC-based multiparametric profiling provides a scalable and sensitive platform for modeling Charcot-Marie-Tooth type 2a.
Induced pluripotent stem cells in structured microphysiological systems: from long-axon neural networks to functional neuromuscular circuits.
The NeuroMuscle™ Platform: A State-of-the-art Microphysiological Neuromuscular Junction System for Disease Modeling and Drug Discovery at the Functional Human Synapse.
3D human NMJ model with iPSC-derived motor neurons + skeletal muscle.
Patient-Specific Human Neuromuscular Junctions-on-a-Chip for Real-time, Label-free Profiling of NMJ Responses to Toxins and Drug Development.
Precisely organized neuronal networks for reproducible screening.
NeuroHTS™: A Structured iPSC-Based OoC Platform Enabling Multiparametric Morphological and Mitochondrial Profiling in Human Neurons.